Teresa Carr

Millions of Americans could benefit from the blockbuster GLP-1 drugs. What would it take to bring down costs?

Federal regulations have been imposed on PFAS. How will a Trump or Harris presidency handle these "forever chemicals"?

Health authorities have said that stockpiled Tamiflu should work well against H5N1. Some experts question that bet.

Avian flu is reported to kill more than half the people it infects. The reality is much more complicated.

As polling methods evolve, it can be hard to distinguish solid findings from those that dissolve under scrutiny.

No single, unified list exists of all species cataloged by humans. Some scientists want that to change.

Something is awry about the way we mark time. Can research and policy changes help us reset the clocks?

Gynecological procedures, such as IUD insertion, are excruciating for some women. Why is pain control so rare?

Through telehealth, it’s easier than ever to get prescription drugs online. Should regulators be paying more attention?

The question is a matter of fierce debate among scientists. Now it’s making its way into the courtroom.

Recent reforms could require companies to perform follow-up studies on drugs that received accelerated approval.

Some researchers argue that civility is a poor metric by which to judge the quality of a debate.

Does the ONA’s “3M Truth in Science Award” imply that journalists and chemical companies are interested in telling the same story?

What could journalists and social scientists shed light on if they had a better view of the digital world?

Can free-market business ventures help contain the cost of prescription drugs? Perhaps, but not for everyone.

Updated algorithms and increased data sharing could improve flight reliability amid a fragile system, scientists say.

Still fighting for recognition in male-dominated fields, some women’s organizations consider moving beyond the binary.

A meta-analysis prompted calls for researchers to disentangle horniness from hype. But understanding desire isn’t easy.

Computational propaganda is ubiquitous, researchers say. But the field of psychology aims to help.

A new paper calls for a halt to skin cancer screenings in the general population. Some physicians vehemently disagree.